Update: A minibus spending package passed by the House of Representatives on January 8, 2026, effectively cancels the Mars Sample Return program by eliminating almost all funding for future missions.

If you don’t know his name, you definitely know his sound. As the man behind the hugely popular Drums That Knock sample libraries, DECAP’s expertly crafted percussion hits have embedded themselves ...

Carter Evans has served as a Los Angeles-based correspondent for CBS News since February 2013, reporting across all of the network's platforms. He joined CBS News with nearly 20 years of journalism ...

Google is bringing theme packs to Pixel phones with a new app in the Google Play Store, available now. While users can download the Theme packs app today, the features will require another system or ...

The New York-based alternative asset manager, which oversees $53 billion, confirmed Pack’s death in a statement but did not provide a cause. “We are devastated by this loss,” Fortress said. Josh Pack, ...

The co-CEO of Fortress Investment Group, Joshua Pack, died unexpectedly on Monday at the age of 51. Pack joined Fortress from Wells Fargo 23 years ago, at first positioned in the credit funds division ...

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announce that Otsuka has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding the ...

Modular synthesizers are some of the most powerful tools in the electronic musician's arsenal, offering a level of flexibility and freedom that's unrivalled by conventional synths. Making it possible ...

We may receive a commission on purchases made from links. Is your car misfiring, having trouble starting, or idling rough? Are you wondering if the problem is one of your coil packs? If you're like ...

A class-action lawsuit over the drug Rexulti has reached a $4.75 million dollar settlement on behalf of patients who took the drug. The lawsuit involves anyone in Canada who was prescribed the drug ...

MONTREAL - Lawyers involved in a class-action lawsuit over the drug Rexulti say a $4.75 million settlement has been reached on behalf of patients and the estates and families of those who were ...